Expertise in
21
conditions

Dr. Ronald L. George

Rheumatology
Medical Center Pharmacy Wha
2421 Silver Stream Ln, 
Wilmington, NC 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
21
conditions
Medical Center Pharmacy Wha
2421 Silver Stream Ln, 
Wilmington, NC 

Overview

Ronald George is a Rheumatologist practicing medicine in Wilmington, North Carolina.

Dr. George is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Behcet Disease, Ankylosing Spondylitis, and Psoriatic Arthritis.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 6 clinical trials. Dr. George is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in RI

Hospital Affiliations

Novant Health New Hanover Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Medical Center Pharmacy Wha
2421 Silver Stream Ln, Wilmington, NC 28401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study
A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects With Rheumatoid Arthritis: The RAjuvenate Study
Enrollment Status: Terminated
Publish Date: October 09, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

2 Total Publications

Genetics of hyperuricemia and gout: implications for the present and future.
Genetics of hyperuricemia and gout: implications for the present and future.
Journal: Current rheumatology reports
Published: January 12, 2013
Similar Doctors
Expertise in
7
conditions
Dr. David H. Snow
Rheumatology
Expertise in
7
conditions
Dr. David H. Snow
Rheumatology
Referral may be required
Before you request

Cape Fear Arthritis Care

1003 Olde Waterford Way Ste 1B, 
Leland, NC 
 (9.3 miles away)
910-679-3212
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Snow is a Rheumatologist practicing medicine in Leland, North Carolina. Dr. Snow is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, and Postmenopausal Osteoporosis. Dr. Snow is currently accepting new patients.

Expertise in
6
conditions
Dr. Max Shenin
Rheumatology
Expertise in
6
conditions
Dr. Max Shenin
Rheumatology
Referral required
Before you request

Novant Health Rheumatology - Autumn Hall

5505 Currituck Drive, Suite 100, 
Wilmington, NC 
 (3.4 miles away)
910-662-7500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Max Shenin is a Rheumatologist practicing medicine in Wilmington, North Carolina. Dr. Shenin is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Systemic Sclerosis (SSc). Dr. Shenin is board certified in Rheumatology. Dr. Shenin is currently accepting new patients.

Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required
Before you request

Medical Center Pharmacy Wha

2421 Silver Stream Ln, 
Wilmington, NC 
 (0.1 miles away)
910-815-7421
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Malithi Jayasundara is a Rheumatologist practicing medicine in Wilmington, North Carolina. Dr. Jayasundara is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Rheumatoid Arthritis (RA), and Psoriatic Arthritis. Dr. Jayasundara is currently accepting new patients.

Frequently Asked Questions about Dr. Ronald L. George

How do I make an appointment with Dr. Ronald L. George?

You can book an appointment with Dr. Ronald L. George by calling their office at 910-815-7421. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ronald L. George a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ronald L. George is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ronald L. George specialize in?

While Dr. Ronald L. George is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Behcet Disease, and Ankylosing Spondylitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Ronald L. George participate in research or clinical trials?

Yes. Dr. Ronald L. George has published 2 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Ronald L. George's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ronald L. George accept my insurance?

Dr. Ronald L. George accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 910-815-7421 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. George's expertise for a condition
ConditionClose
      View All 21 Advanced Conditions
      View All 25 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile